Pazopanib Hydrochloride Tablets is a targeted anticancer medicine used to treat certain advanced kidney cancers and advanced soft tissue sarcomas.
Key Benefits
- Used in the treatment of certain advanced renal cell carcinoma
- Helps manage advanced soft tissue sarcomas in appropriate patients
- Inhibits pathways involved in tumor growth
- Helps reduce the formation of new blood vessels that support tumor growth
- Provides targeted anticancer activity in selected cancer conditions
How It Works
Pazopanib inhibits several tyrosine kinases, including receptors involved in vascular endothelial growth factor and platelet-derived growth factor signaling. By blocking these pathways, it can interfere with cancer-cell growth and angiogenesis, the formation of new blood vessels that tumors require for continued growth.
Common Side Effects
- Diarrhea
- Nausea
- Loss of appetite
- Fatigue
- Hair color changes
- High blood pressure
- Changes in taste
- Skin and nail changes
- Headache
- Abdominal discomfort
Important Information
Pazopanib Hydrochloride Tablets should be used only under the supervision of a qualified oncologist. Regular monitoring of blood pressure, liver function, blood counts, and other clinical parameters may be required during treatment. Pazopanib can cause serious liver problems, high blood pressure, bleeding, heart-related complications, and changes in thyroid function. It may also affect wound healing, so inform your healthcare professional before planned surgery. Tell your doctor about all medicines and supplements you are taking because significant drug interactions may occur. Seek immediate medical attention for severe abdominal pain, unusual bleeding, chest pain, breathing difficulty, yellowing of the skin or eyes, or other serious symptoms.